Skip to main content

Allergy

  • A global look at an ever-changing market

    There’s a global race right now to become the global drug chain leader. It brings three very different things together: the board game Risk, an iceberg and a Bob Dylan song. I’ll explain.

  • HRG introduces cross-merchandising infographic series

    WAUKESHA, Wis. — Hamacher Resource Group on Wednesday introduced a new infographic series to help community pharmacies maximize sales. "Increasing the Market Basket — Ideas for Cross-Selling Merchandise," offers suggested complementary items to add to front-end health, beauty and wellness departments as space is available to improve the shopper experience and increase impulse purchases.

  • We are all the New General Market

    In April, Drug Store News and Mack Elevation co-hosted the third annual New General Market Summit. The one-day thought leadership event examined the changing face of the American shopper — driven not only by the growth of multicultural and millennial consumers but also by the influence these consumers are having on all consumers — and how the best brands are able to connect on an emotional level, as well as build community and advocacy with an ever-more diverse consumer.

  • ECRM acquires product discovery platform RangeMe

    SOLON, Ohio and SAN FRANCISCO — Efficient Collaborative Retail Marketing has acquired a technology company that has been changing how retailers discover new suppliers.

    The company on Tuesday announced the acquisition of RangeMe, which streamlines new product discovery in a way that ECRM said will complement the foundation it has laid in helping buyers discover new products and improve category planning effectiveness.

  • Allegra Allergy supports Bike to Work Day events across the country

    RIDGEWATER, N.J. — Sanofi Consumer Healthcare – the makers of Allegra Allergy – on Thursday announced that it is supporting Bike to Work Day events across the country as a way to help reduce air pollution and to get more people outdoors this spring.

  • Sanofi's Xyzal is nothing to sneeze at as it contributes to strong first-quarter gains

    CHATTANOOGA, Tenn. — Sanofi posted first quarter gains of 18.7% across its U.S. consumer healthcare business, the company reported Friday, reaching sales of $380.1 million. The growth was driven in large part by the February launch of the Xyzal Allergy 24HR, which generated $47 million in sales in just two months on the shelf.  

  • The Weather Company renews Allergy Tracker collaboration with GSK Consumer Healthcare

    NEW YORK — The Weather Company on Tuesday renewed its collaboration with GSK Consumer Healthcare and PHD Media Worldwide. As part of their continued relationship, Weather has introduced an enhanced Allergy Tracker, which includes increased personalization capabilities. The Allergy Tracker also delivers a comprehensive experience where all the variables around managing allergies is available in the same place, including current weather conditions, hyper-local allergy reports, expanded forecasts and editorial content.

X
This ad will auto-close in 10 seconds